GlassScriptPhysician profile
Reilly Carr
NPI 1396400461
$2,868.14
in general payments reported to CMS, 2019-2025
19 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $796 · 2023: $134 · 2024: $1,721 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,350 · Food and Beverage: $624 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,350.31 |
| Food and Beverage | $623.79 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,736.26 | 2023-2024 | Stratafix |
| Stryker Corporation | $232.21 | 2024-2025 | Triathlon, Mako, Accolade |
| Antares Pharma, INC. | $187.33 | 2022 | |
| Astellas Pharma US INC | $168.46 | 2022 | |
| Axonics, INC. | $148.98 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $62.76 | 2022-2023 | Iovera, Exparel, Zilretta |
| Urogen Pharma, INC. | $47.11 | 2022 | |
| Urovant Sciences INC | $46.58 | 2022 | |
| Ethicon US, LLC | $36.74 | 2024 | Stratafix |
| Olympus America INC. | $28.45 | 2022 | |
| Abbvie INC. | $26.06 | 2022 | |
| Teleflex LLC | $23.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2022 | |
| Merck Sharp & Dohme LLC | $20.49 | 2022 | |
| Boston Scientific Corporation | $18.47 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $16.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.18 | 2022 | |
| Heron Therapeutics, INC. | $15.83 | 2025 | Zynrelef |
| Phathom Pharmaceuticals, INC. | $15.12 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reilly Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.